ARTICLE | Clinical News
Scynexis, Merck preclinical data
October 11, 2010 7:00 AM UTC
In mice inoculated with Aspergillus fumigatus spores, MK-3118 initiated within 15-30 minutes after challenge and continued twice-daily for 7 days led to survival rates of up to 90% at day 14 post-infe...